MYC dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer
ManSai Acón, Carsten Geiß, Jorge Torres-Calvo, Diana M. Bravo‐Estupiñan, Guillermo R. Oviedo, Jorge L. Arias-Arias, Luis A. Rojas-Matey, Edwin Baéz, Gloriana Vásquez-Vargas, Yendry Oses-Vargas, José Guevara-Coto, Andrés Segura-Castillo, Francisco Siles-Canales, Steve Quirós-Barrantes, Anne Régnier‐Vigouroux, Pedro Mendes, Rodrigo Mora-Rodríguez
Abstract
dosage compensation with patient survival in TCGA breast cancer patients, highlighting the potential of this mechanism to prevent aneuploid cancer progression.
Topics & Concepts
microRNAGene dosageTranscription factorBiologyCancer researchDosage compensationCancerGeneCancer cellEndogenyDownregulation and upregulationGene expressionBioinformaticsGeneticsBiochemistryRNA Research and SplicingGenomics and Chromatin DynamicsMicroRNA in disease regulation